Evidence map›Paper›PMID 25336647›Full record

ArticleThe Journal of biological chemistry2014

Inter-domain communication of human cystathionine β-synthase: structural basis of S-adenosyl-L-methionine activation.

Thomas J McCorvie, Jolanta Kopec, Suk-Joon Hyung, Fiona Fitzpatrick, Xidong Feng, Daniel Termine, Claire Strain-Damerell, Melanie Vollmar, James Fleming, Jay M Janz and 2 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. HCellular and molecular life sciences : CMLS · 2022
    Article
  15. Article
  16. Review
  17. Structural insight into the unique conformation of cystathionine β-synthase fromComputational and structural biotechnology journal · 2021
    Article
  18. Article
  19. Review
  20. Hydrogen Sulfide Metabolism and Signaling in the Tumor Microenvironment.Advances in experimental medicine and biology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Thomas J McCorvieFrom the Structural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 7DQ, United Kingdom.
Jolanta KopecFrom the Structural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 7DQ, United Kingdom.
Suk-Joon HyungWorldwide Research and Development, Pfizer Inc., Groton, Connecticut 06340, and.
Fiona FitzpatrickFrom the Structural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 7DQ, United Kingdom.
Xidong FengWorldwide Research and Development, Pfizer Inc., Groton, Connecticut 06340, and.
Daniel Terminethe Pfizer Rare Disease Research Unit, Worldwide Research and Development, Pfizer Inc., Cambridge, Massachusetts 02140.
Claire Strain-DamerellFrom the Structural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 7DQ, United Kingdom.
Melanie VollmarFrom the Structural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 7DQ, United Kingdom.
James Flemingthe Pfizer Rare Disease Research Unit, Worldwide Research and Development, Pfizer Inc., Cambridge, Massachusetts 02140.
Jay M Janzthe Pfizer Rare Disease Research Unit, Worldwide Research and Development, Pfizer Inc., Cambridge, Massachusetts 02140.
Christine Bulawathe Pfizer Rare Disease Research Unit, Worldwide Research and Development, Pfizer Inc., Cambridge, Massachusetts 02140 christine.bulawa@pfizer.com.
Wyatt W YueFrom the Structural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 7DQ, United Kingdom, wyatt.yue@sgc.ox.ac.uk.
Pfizer (United States) · USGenomics (United Kingdom) · GBUniversity of Oxford · GB

Funding

Wellcome Trust 092809Wellcome Trust WT099376MA
6 · The paper itself

Abstract

Cystathionine β-synthase (CBS) is a key enzyme in sulfur metabolism, and its inherited deficiency causes homocystinuria. Mammalian CBS is modulated by the binding of S-adenosyl-l-methionine (AdoMet) to its regulatory domain, which activates its catalytic domain. To investigate the underlying mechanism, we performed x-ray crystallography, mutagenesis, and mass spectrometry (MS) on human CBS. The 1.7 Å structure of a AdoMet-bound CBS regulatory domain shows one AdoMet molecule per monomer, at the interface between two constituent modules (CBS-1, CBS-2). AdoMet binding is accompanied by a reorientation between the two modules, relative to the AdoMet-free basal state, to form interactions with AdoMet via residues verified by mutagenesis to be important for AdoMet binding (Phe(443), Asp(444), Gln(445), and Asp(538)) and for AdoMet-driven inter-domain communication (Phe(443), Asp(538)). The observed structural change is further supported by ion mobility MS, showing that as-purified CBS exists in two conformational populations, which converged to one in the presence of AdoMet. We therefore propose that AdoMet-induced conformational change alters the interface and arrangement between the catalytic and regulatory domains within the CBS oligomer, thereby increasing the accessibility of the enzyme active site for catalysis.

Indexed as

Catalytic DomainCrystallography, X-RayCystathionine beta-SynthaseHumansHydrogen BondingModels, MolecularProtein BindingProtein Structure, SecondaryS-AdenosylmethionineCystathionine beta-SynthaseS-AdenosylmethionineActivationAllosteric RegulationConformational ChangeCrystallographyCystathionine β-SynthaseEnzymeMass Spectrometry (MS)S-adenosyl-l-methionine (AdoMet)SAM

Identifiers

PMID25336647
PMCPMC4276868
OpenAlexW1992550773

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.